Gene therapy for the nervous system: challenges and new strategies

Area of Science:

• Neuroscience
• Genetics
• Biotechnology

Background:

• Current treatments for central nervous system (CNS) diseases, including Parkinson's disease and glioblastoma, are often palliative and associated with significant side effects.
• Gene therapy presents a potential curative strategy by correcting genetic deficiencies, modulating gene expression, or inducing cancer cell death.

Purpose of the Study:

• This review focuses on the challenges and strategies for developing effective gene-based neurotherapeutics.
• Key challenges addressed include gene delivery vehicles, promoter selection for CNS gene expression, and overcoming the blood-brain barrier.

Main Methods:

• The review synthesizes current research on viral and nonviral delivery systems for gene therapy in the CNS.
• It examines the role of specific promoters in achieving targeted gene expression within the central nervous system.
• Strategies for enhancing gene product delivery across the blood-brain barrier are discussed.

Main Results:

• Gene therapy has demonstrated potential in clinical trials for conditions like Leber's congenital amaurosis and Parkinson's disease.
• Advances in genome editing technologies (zinc finger nucleases, TALENs, CRISPR) are bringing gene correction closer to reality.
• Promising preclinical and clinical studies highlight the therapeutic potential of gene-based neurotherapeutics.

Conclusions:

• Gene therapy holds significant promise for treating debilitating CNS diseases, offering a potential for permanent correction.
• Addressing critical hurdles in gene delivery, expression control, and blood-brain barrier penetration is essential for clinical success.
• Continued research and technological advancements are paving the way for the broader application of gene-based neurotherapeutics.